Cryptorchidism refers to the failure of one or both testes to descend into the scrotum and affects approximately 1–4% of full-term male newborns. The incidence is considerably higher in premature infants, reaching nearly 30% [15]. In many cases, spontaneous descent occurs during the first few months of life, resulting in a prevalence of nearly 1% by the age of one year [15]. Persistent undescended testes are clinically important because delayed treatment may adversely affect spermatogenesis and endocrine function, while also increasing the risks of testicular torsion, trauma, inguinal hernia, and malignant transformation [2,4,5,6]. In addition, cosmetic concerns and psychological distress may develop later in life.

Traditionally, open inguinal orchiopexy was the standard treatment for palpable undescended testes. However, the development of minimally invasive surgery has transformed the management of cryptorchidism, especially in patients with non-palpable testes. Laparoscopy now serves both diagnostic and therapeutic purposes and has become the preferred modality in many pediatric urology centers worldwide [1,8,9].

DIAGNOSTIC SUPERIORITY OF LAPAROSCOPY

One of the major advantages of laparoscopy is its superior diagnostic capability, particularly in children with non-palpable testes. Approximately 20% of cryptorchid testes are non-palpable, and preoperative imaging often has limited reliability in these cases [9]. Ultrasonography demonstrates poor sensitivity for locating intra-abdominal testes, while magnetic resonance imaging, although more accurate, is expensive and not universally available. Diagnostic laparoscopy allows direct visualization of the abdominal cavity, internal inguinal ring, spermatic vessels, vas deferens, and any intra-abdominal gonadal tissue [1,9,12]. It can reliably identify viable testes, atrophic remnants, blind-ending vessels suggestive of vanished testis syndrome, or testes entering the inguinal canal. This ability to establish diagnosis and proceed immediately to treatment under the same anesthesia provides a major advantage over conventional open exploration.

THERAPEUTIC EFFECTIVENESS

Laparoscopic orchiopexy has demonstrated consistently favorable therapeutic outcomes in the literature. Reported overall success rates range between 85% and 95%, depending on the location of the testis and the operative technique used [1,3,8,10,11]. For low intra-abdominal testes with adequate cord length, primary laparoscopic orchiopexy achieves success rates exceeding 90% [1,3]. In higher testes where vascular length is limited, staged Fowler–Stephens orchiopexy remains an effective option, with reported success rates of approximately 80–89% [10]. Rates of testicular atrophy are generally low, often below 10%, while recurrence or re-ascent after surgery is uncommon [8,10,11]. These outcomes compare favorably with traditional open techniques and have contributed significantly to the widespread acceptance of laparoscopy.

ADVANTAGES OVER OPEN SURGERY

Compared with open surgery, laparoscopy offers several clinical advantages. The magnified panoramic view permits precise identification of anatomical structures and facilitates meticulous dissection while preserving the vas deferens and vascular supply [8,9]. Because the procedure is minimally invasive, postoperative pain is usually less severe, recovery is faster, and hospital stay is shorter. Many patients can be managed as day-care surgical cases [1,8]. The cosmetic outcome is also superior due to the use of small trocar incisions instead of larger groin or abdominal scars. In bilateral cases, laparoscopy also allows simultaneous evaluation and treatment of both sides without additional incisions [9].

SAFETY PROFILE

The safety profile of laparoscopic orchiopexy is well established. Contemporary studies have reported low complication rates comparable to or lower than those associated with open surgery [1,8]. Significant intraoperative complications such as bowel injury, major bleeding, or damage to the vas deferens are rare when the procedure is performed by experienced surgeons. Postoperative wound infection is uncommon, and most children recover quickly with minimal analgesic requirements [4]. Testicular atrophy and recurrence rates remain low, further supporting the reliability of this approach [10,11].

STANDARD OF CARE IN NON-PALPABLE TESTIS

Laparoscopy is now widely regarded as the preferred approach for the management of non-palpable testes. It enables the surgeon to determine intraoperatively whether the testis is absent, atrophic, intracanalicular, or truly intra-abdominal, and to select the most appropriate intervention accordingly [1,9,12]. Depending on operative findings, the surgeon may proceed with standard orchiopexy, staged Fowler–Stephens orchiopexy, orchiectomy for a severely dysplastic gonad, or conclude the procedure if a vanished testis is confirmed. This flexibility and accuracy have led many contemporary guidelines to recommend laparoscopy as the first-line management strategy in non-palpable cryptorchidism [8,14].

IMPORTANCE OF EARLY SURGICAL TIMING

Current pediatric urology recommendations advise orchiopexy between 6 and 18 months of age, ideally before one year when feasible [8,14]. Early intervention is associated with improved germ cell preservation, better fertility potential, and easier mobilization of tissues [7,8]. Delayed correction may result in progressive histological damage to seminiferous tubules and Leydig cell dysfunction [7]. Timely surgery also improves long-term surveillance for testicular malignancy.

FERTILITY AND MALIGNANCY CONSIDERATIONS

Although orchiopexy improves outcomes, patients with a history of cryptorchidism continue to carry a higher lifetime risk of testicular cancer compared with the general population [5,6]. However, relocating the testis into the scrotum facilitates clinical examination and earlier detection of abnormalities. Bilateral cryptorchidism is more strongly associated with infertility than unilateral disease, emphasizing the importance of prompt diagnosis and management [4].

LIMITATIONS OF LAPAROSCOPY

Despite its clear advantages, laparoscopy has certain limitations. It requires specialized instruments, trained personnel, and an operating theater equipped for minimally invasive surgery. Initial costs may therefore be higher in low-resource settings. In addition, the benefits of laparoscopy are less pronounced in low palpable inguinal testes, where conventional open orchiopexy remains highly effective, simpler, and more economical [8].

FUTURE PERSPECTIVES

Advances in minimally invasive surgery continue to refine the management of cryptorchidism. Single-incision laparoscopic surgery aims to further improve cosmesis, while robotic-assisted orchiopexy may offer ergonomic advantages and greater dexterity. Novel technologies such as fluorescence-guided vascular imaging may assist in preserving testicular blood supply during complex procedures. However, at present, these innovations have not demonstrated clear superiority over standard laparoscopy in terms of outcomes or cost-effectiveness.

CONCLUSION

Laparoscopy has transformed the management of cryptorchidism by combining precise diagnosis with definitive treatment through a minimally invasive approach. It offers excellent visualization, high success rates, low morbidity, rapid recovery, and superior cosmetic outcomes. Its value is particularly evident in non-palpable and intra-abdominal testes, where conventional methods are less reliable. Based on current evidence and modern clinical practice, laparoscopic orchiopexy should be considered the gold standard in the management of complex cryptorchidism.

REFERENCES

1. Han H, Li J, Lei H, Yin H, Tian L. Laparoscopic orchidopexy for the treatment of cryptorchidism in adults: a description of the technique and outcomes. BMC Urol. 2024;24(1):1.
2. Elamo HP, Virtanen HE, Toppari J. Genetics of cryptorchidism and testicular regression. Best Pract Res Clin Endocrinol Metab. 2022;36(1):101619.
3. Omoto K, Nishihara Y, Kawaguchi Y, Urakami H, Seki S, Ohishi T, Isobe Y, Matsumoto S. Laparoscopic orchidopexy with transabdominal preperitoneal hernia repair in an adult. Asian J Endosc Surg. 2017;10(3):325-327.
4. Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992;111(5):518-526.
5. Goel P, Rawat J, Wakhlu A, Kureel S. Undescended testicle: an update on fertility in cryptorchid men. Indian J Med Res. 2015;141(2):163-171.
6. Nallu A, Mannuel HD, Hussain A. Testicular germ cell tumors: biology and clinical update. Curr Opin Oncol. 2013;25(3):266-272.
7. Mikuz G. Update on the pathology of testicular tumors. Anal Quant Cytopathol Histpathol. 2015;37(1):75-85.
8. Batra NV, DeMarco RT, Bayne CE. A narrative review of the history and evidence-base for the timing of orchidopexy for cryptorchidism. J Pediatr Urol. 2021;17(2):239-245.
9. Khairi A, Shehata S, El-Kholi N. Is it necessary to close the peritoneum over the deep inguinal ring during laparoscopic orchidopexy? J Pediatr Urol. 2013;9(2):157-160.
10. Elyas R, Guerra LA, Pike J, DeCarli C, Betolli M, Bass J, et al. Is staging beneficial for Fowler-Stephens orchiopexy? A systematic review. J Urol. 2010;183:2012-2018.
11. Shehata SM. Laparoscopically assisted gradual controlled traction on the testicular vessels: A new concept in the management of abdominal testis. Eur J Pediatr Surg. 2008;18:402-406.
12. Sousa A, Gayoso R, Lopez-Bellido D, Reboredo J, Perez-Valcarcel J, Fuentes M. Laparoscopic assessment and orchidectomy for the adult undescended testis. Surg Laparosc Endosc Percutan Tech. 2000;10:420-422.
13. Salah SE, Elhaj KI, Awadelseed YO, Mohammed SG. Crossed testicular ectopia: A case report and review of the literature. Ann Pediatr Surg. 2016;12:170-172.
14. Yi W, Sheng-de W, Lian-Ju S, Tao L, Da-Wei H, Guang-Hui W. Management of undescended testis may be improved with educational updates and new transferring model. Ital J Pediatr. 2018;44:58.
15. Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, Holzman IR. Prevalence and natural history of cryptorchidism. Pediatrics. 1993;92:44-49.